位置:首页 > 蛋白库 > EOMES_HUMAN
EOMES_HUMAN
ID   EOMES_HUMAN             Reviewed;         686 AA.
AC   O95936; B7Z4I2; B7ZA51; G3XAI5; Q8TAZ2; Q9UPM7;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 3.
DT   03-AUG-2022, entry version 179.
DE   RecName: Full=Eomesodermin homolog;
DE   AltName: Full=T-box brain protein 2;
DE            Short=T-brain-2;
DE            Short=TBR-2;
GN   Name=EOMES; Synonyms=TBR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10407135; DOI=10.1016/s0165-3806(99)00064-4;
RA   Kimura N., Nakashima K., Ueno M., Taga T.;
RT   "A novel mammalian T-box-containing gene, Tbr2, expressed in mouse
RT   developing brain.";
RL   Brain Res. Dev. Brain Res. 115:183-193(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RX   PubMed=18316326; DOI=10.1093/dnares/dsn004;
RA   Nagase T., Yamakawa H., Tadokoro S., Nakajima D., Inoue S., Yamaguchi K.,
RA   Itokawa Y., Kikuno R.F., Koga H., Ohara O.;
RT   "Exploration of human ORFeome: high-throughput preparation of ORF clones
RT   and efficient characterization of their protein products.";
RL   DNA Res. 15:137-149(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 291-455 (ISOFORM 1).
RX   PubMed=9888994; DOI=10.1006/geno.1998.5632;
RA   Yi C.-H., Terrett J.A., Li Q.-Y., Ellington K., Packham E.A.,
RA   Amstrong-Buisseret L., McClure P., Slingsby T., Brook J.D.;
RT   "Identification, mapping and phylogenomic analysis of four new human
RT   members of the T-box gene family: EOMES, TBX6, TBX18, and TBX19.";
RL   Genomics 55:10-20(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 297-686 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=17566017; DOI=10.1136/gut.2006.117812;
RA   Atreya I., Schimanski C.C., Becker C., Wirtz S., Dornhoff H., Schnuerer E.,
RA   Berger M.R., Galle P.R., Herr W., Neurath M.F.;
RT   "The T-box transcription factor eomesodermin controls CD8 T cell activity
RT   and lymph node metastasis in human colorectal cancer.";
RL   Gut 56:1572-1578(2007).
RN   [9]
RP   FUNCTION IN BRAIN DEVELOPMENT, AND DEVELOPMENTAL STAGE.
RX   PubMed=17353897; DOI=10.1038/ng1993;
RA   Baala L., Briault S., Etchevers H.C., Laumonnier F., Natiq A., Amiel J.,
RA   Boddaert N., Picard C., Sbiti A., Asermouh A., Attie-Bitach T.,
RA   Encha-Razavi F., Munnich A., Sefiani A., Lyonnet S.;
RT   "Homozygous silencing of T-box transcription factor EOMES leads to
RT   microcephaly with polymicrogyria and corpus callosum agenesis.";
RL   Nat. Genet. 39:454-456(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] GLN-667.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Functions as a transcriptional activator playing a crucial
CC       role during development. Functions in trophoblast differentiation and
CC       later in gastrulation, regulating both mesoderm delamination and
CC       endoderm specification. Plays a role in brain development being
CC       required for the specification and the proliferation of the
CC       intermediate progenitor cells and their progeny in the cerebral cortex.
CC       Also involved in the differentiation of CD8+ T-cells during immune
CC       response regulating the expression of lytic effector genes.
CC       {ECO:0000269|PubMed:17353897, ECO:0000269|PubMed:17566017}.
CC   -!- INTERACTION:
CC       O95936-4; Q5XKR4: OTP; NbExp=3; IntAct=EBI-19949518, EBI-12865884;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O95936-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95936-2; Sequence=VSP_042161, VSP_042162;
CC       Name=3;
CC         IsoId=O95936-3; Sequence=VSP_054801, VSP_042162;
CC       Name=4;
CC         IsoId=O95936-4; Sequence=VSP_042162;
CC   -!- TISSUE SPECIFICITY: Expressed in CD8+ T-cells.
CC       {ECO:0000269|PubMed:17566017}.
CC   -!- DEVELOPMENTAL STAGE: Detected at 7 weeks of development in the
CC       forebrain floorplate of the CNS. Expressed within the mantle layer and
CC       migrating neuroblasts of the telencephalon at 12.5 weeks of
CC       development. {ECO:0000269|PubMed:17353897}.
CC   -!- INDUCTION: Up-regulated in CD8+ T-cells simultaneously stimulated with
CC       TGFB1 and IL4/interleukin-4. {ECO:0000269|PubMed:17566017}.
CC   -!- DISEASE: Note=A translocation t(3;10)(p24;q23) located 215 kb 3' to the
CC       EOMES gene but leading to loss of its expression was identified in a
CC       large consanguineous family. Homozygous silencing produces microcephaly
CC       associated with corpus callosum agenesis, bilateral polymicrogyria,
CC       ventricular dilatation and a small cerebellum.
CC   -!- MISCELLANEOUS: [Isoform 2]: Dubious isoform produced through aberrant
CC       splice sites. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB031038; BAA83417.1; -; mRNA.
DR   EMBL; AK297389; BAH12568.1; -; mRNA.
DR   EMBL; AK316166; BAH14537.1; -; mRNA.
DR   EMBL; AB463608; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC098614; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471055; EAW64388.1; -; Genomic_DNA.
DR   EMBL; AJ010280; CAB37939.1; -; Genomic_DNA.
DR   EMBL; BC025363; AAH25363.1; -; mRNA.
DR   CCDS; CCDS2646.1; -. [O95936-1]
DR   CCDS; CCDS63584.1; -. [O95936-3]
DR   CCDS; CCDS63585.1; -. [O95936-4]
DR   RefSeq; NP_001265111.1; NM_001278182.1. [O95936-4]
DR   RefSeq; NP_001265112.1; NM_001278183.1. [O95936-3]
DR   RefSeq; NP_005433.2; NM_005442.3. [O95936-1]
DR   AlphaFoldDB; O95936; -.
DR   SMR; O95936; -.
DR   BioGRID; 113916; 2.
DR   IntAct; O95936; 4.
DR   MINT; O95936; -.
DR   STRING; 9606.ENSP00000388620; -.
DR   iPTMnet; O95936; -.
DR   PhosphoSitePlus; O95936; -.
DR   BioMuta; EOMES; -.
DR   jPOST; O95936; -.
DR   MassIVE; O95936; -.
DR   MaxQB; O95936; -.
DR   PaxDb; O95936; -.
DR   PeptideAtlas; O95936; -.
DR   PRIDE; O95936; -.
DR   ProteomicsDB; 33758; -.
DR   ProteomicsDB; 51135; -. [O95936-1]
DR   ProteomicsDB; 51136; -. [O95936-2]
DR   ProteomicsDB; 7055; -.
DR   Antibodypedia; 11523; 452 antibodies from 40 providers.
DR   DNASU; 8320; -.
DR   Ensembl; ENST00000295743.8; ENSP00000295743.4; ENSG00000163508.13. [O95936-1]
DR   Ensembl; ENST00000449599.4; ENSP00000388620.1; ENSG00000163508.13. [O95936-4]
DR   Ensembl; ENST00000461503.2; ENSP00000487112.1; ENSG00000163508.13. [O95936-3]
DR   GeneID; 8320; -.
DR   KEGG; hsa:8320; -.
DR   MANE-Select; ENST00000449599.4; ENSP00000388620.1; NM_001278182.2; NP_001265111.1. [O95936-4]
DR   UCSC; uc003cdx.5; human. [O95936-1]
DR   CTD; 8320; -.
DR   DisGeNET; 8320; -.
DR   GeneCards; EOMES; -.
DR   HGNC; HGNC:3372; EOMES.
DR   HPA; ENSG00000163508; Group enriched (brain, lymphoid tissue).
DR   MalaCards; EOMES; -.
DR   MIM; 604615; gene.
DR   neXtProt; NX_O95936; -.
DR   OpenTargets; ENSG00000163508; -.
DR   Orphanet; 171703; Microcephaly-polymicrogyria-corpus callosum agenesis syndrome.
DR   PharmGKB; PA27806; -.
DR   VEuPathDB; HostDB:ENSG00000163508; -.
DR   eggNOG; KOG3585; Eukaryota.
DR   GeneTree; ENSGT00940000158728; -.
DR   HOGENOM; CLU_014430_8_1_1; -.
DR   InParanoid; O95936; -.
DR   OMA; YGPYPGT; -.
DR   PhylomeDB; O95936; -.
DR   TreeFam; TF106341; -.
DR   PathwayCommons; O95936; -.
DR   SignaLink; O95936; -.
DR   SIGNOR; O95936; -.
DR   BioGRID-ORCS; 8320; 13 hits in 1090 CRISPR screens.
DR   GeneWiki; Eomesodermin; -.
DR   GenomeRNAi; 8320; -.
DR   Pharos; O95936; Tbio.
DR   PRO; PR:O95936; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; O95936; protein.
DR   Bgee; ENSG00000163508; Expressed in ganglionic eminence and 124 other tissues.
DR   Genevisible; O95936; HS.
DR   GO; GO:0000785; C:chromatin; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0031490; F:chromatin DNA binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISS:BHF-UCL.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0048708; P:astrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IMP:UniProtKB.
DR   GO; GO:0010002; P:cardioblast differentiation; IEA:Ensembl.
DR   GO; GO:0002302; P:CD8-positive, alpha-beta T cell differentiation involved in immune response; IMP:UniProtKB.
DR   GO; GO:0060706; P:cell differentiation involved in embryonic placenta development; ISS:UniProtKB.
DR   GO; GO:0001708; P:cell fate specification; IBA:GO_Central.
DR   GO; GO:0021895; P:cerebral cortex neuron differentiation; IEA:Ensembl.
DR   GO; GO:0021796; P:cerebral cortex regionalization; IEA:Ensembl.
DR   GO; GO:0006338; P:chromatin remodeling; IEA:Ensembl.
DR   GO; GO:0080111; P:DNA demethylation; IEA:Ensembl.
DR   GO; GO:0006306; P:DNA methylation; IEA:Ensembl.
DR   GO; GO:0001706; P:endoderm formation; ISS:UniProtKB.
DR   GO; GO:0001714; P:endodermal cell fate specification; IBA:GO_Central.
DR   GO; GO:0010467; P:gene expression; IEA:Ensembl.
DR   GO; GO:0016573; P:histone acetylation; IEA:Ensembl.
DR   GO; GO:0016575; P:histone deacetylation; IEA:Ensembl.
DR   GO; GO:0048382; P:mesendoderm development; IEA:Ensembl.
DR   GO; GO:0001707; P:mesoderm formation; ISS:UniProtKB.
DR   GO; GO:0060809; P:mesodermal to mesenchymal transition involved in gastrulation; ISS:UniProtKB.
DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; ISS:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:BHF-UCL.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0021772; P:olfactory bulb development; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:MGI.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0019827; P:stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0001829; P:trophectodermal cell differentiation; IEA:Ensembl.
DR   CDD; cd00182; TBOX; 1.
DR   Gene3D; 2.60.40.820; -; 1.
DR   InterPro; IPR008967; p53-like_TF_DNA-bd.
DR   InterPro; IPR032385; T-box_assoc.
DR   InterPro; IPR046360; T-box_DNA-bd.
DR   InterPro; IPR036960; T-box_sf.
DR   InterPro; IPR001699; TF_T-box.
DR   InterPro; IPR018186; TF_T-box_CS.
DR   PANTHER; PTHR11267; PTHR11267; 1.
DR   Pfam; PF00907; T-box; 1.
DR   Pfam; PF16176; T-box_assoc; 1.
DR   PRINTS; PR00937; TBOX.
DR   SMART; SM00425; TBOX; 1.
DR   SUPFAM; SSF49417; SSF49417; 1.
DR   PROSITE; PS01283; TBOX_1; 1.
DR   PROSITE; PS01264; TBOX_2; 1.
DR   PROSITE; PS50252; TBOX_3; 1.
PE   1: Evidence at protein level;
KW   Activator; Adaptive immunity; Alternative splicing;
KW   Chromosomal rearrangement; Developmental protein; Differentiation;
KW   DNA-binding; Gastrulation; Immunity; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN           1..686
FT                   /note="Eomesodermin homolog"
FT                   /id="PRO_0000184459"
FT   DNA_BIND        276..456
FT                   /note="T-box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00201"
FT   REGION          27..46
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          571..686
FT                   /note="Required for transcription activation"
FT                   /evidence="ECO:0000250"
FT   REGION          639..686
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        639..659
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         107
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O54839"
FT   VAR_SEQ         1..295
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054801"
FT   VAR_SEQ         1..286
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042161"
FT   VAR_SEQ         460
FT                   /note="S -> SMYTASENDRLTPSPTDSPR (in isoform 2, isoform 3
FT                   and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:18316326"
FT                   /id="VSP_042162"
FT   VARIANT         120
FT                   /note="A -> G (in dbSNP:rs1874198)"
FT                   /id="VAR_059827"
FT   VARIANT         667
FT                   /note="E -> Q (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036069"
FT   CONFLICT        49
FT                   /note="D -> G (in Ref. 1; BAA83417)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        142
FT                   /note="E -> V (in Ref. 1; BAA83417)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        200
FT                   /note="V -> A (in Ref. 1; BAA83417)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        221..222
FT                   /note="SS -> IN (in Ref. 1; BAA83417)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        262
FT                   /note="G -> S (in Ref. 1; BAA83417)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        337
FT                   /note="C -> S (in Ref. 6; CAB37939)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        411
FT                   /note="E -> EK (in Ref. 6; CAB37939)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        415
FT                   /note="E -> D (in Ref. 6; CAB37939)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        661
FT                   /note="E -> G (in Ref. 1; BAA83417)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        685
FT                   /note="T -> S (in Ref. 1; BAA83417)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   686 AA;  72732 MW;  1A6BA0763C5A6681 CRC64;
     MQLGEQLLVS SVNLPGAHFY PLESARGGSG GSAGHLPSAA PSPQKLDLDK ASKKFSGSLS
     CEAVSGEPAA ASAGAPAAML SDTDAGDAFA SAAAVAKPGP PDGRKGSPCG EEELPSAAAA
     AAAAAAAAAA TARYSMDSLS SERYYLQSPG PQGSELAAPC SLFPYQAAAG APHGPVYPAP
     NGARYPYGSM LPPGGFPAAV CPPGRAQFGP GAGAGSGAGG SSGGGGGPGT YQYSQGAPLY
     GPYPGAAAAG SCGGLGGLGV PGSGFRAHVY LCNRPLWLKF HRHQTEMIIT KQGRRMFPFL
     SFNINGLNPT AHYNVFVEVV LADPNHWRFQ GGKWVTCGKA DNNMQGNKMY VHPESPNTGS
     HWMRQEISFG KLKLTNNKGA NNNNTQMIVL QSLHKYQPRL HIVEVTEDGV EDLNEPSKTQ
     TFTFSETQFI AVTAYQNTDI TQLKIDHNPF AKGFRDNYDS SHQIVPGGRY GVQSFFPEPF
     VNTLPQARYY NGERTVPQTN GLLSPQQSEE VANPPQRWLV TPVQQPGTNK LDISSYESEY
     TSSTLLPYGI KSLPLQTSHA LGYYPDPTFP AMAGWGGRGS YQRKMAAGLP WTSRTSPTVF
     SEDQLSKEKV KEEIGSSWIE TPPSIKSLDS NDSGVYTSAC KRRRLSPSNS SNENSPSIKC
     EDINAEEYSK DTSKGMGGYY AFYTTP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025